(Q40457638)

20 September 2017

1 reference

title

5-Hydroxytryptamine pathways in anxiety and its treatment (English)

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

23 June 2024

author name string

S. L. Handley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630926

23 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7630926

23 June 2024

publication date

1 April 1995

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:016372589500004Z?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

https://api.elsevier.com/content/article/PII:016372589500004Z?httpAccept=text/plain

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Pharmacology & Therapeutics

23 June 2024

published in

1 reference

20 September 2017

volume

66

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

103-148

1 reference

Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study.

20 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

In vivo brain dialysis study of the somatodendritic release of serotonin in the Raphe nuclei of the rat: effects of 8-hydroxy-2-(di-n-propylamino)tetralin

23 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Decreased reactivity to anxiolytics caused by early protein malnutrition in rats.

23 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Comparison of the anticonflict effect of buspirone and its major metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in rats.

23 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Evaluation of a psychophysiological model of classical fear conditioning in anxious patients.

23 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Benzodiazepine receptors in the periaqueductal grey mediate anti-aversive drug action.

23 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Mediation by serotonin of the antiaversive effect of zimelidine and propranolol injected into the dorsal midbrain central grey

23 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 2. Psychopathological symptoms.

23 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model

23 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Fluoxetine: a review of receptor and functional effects and their clinical implications.

23 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Attenuation of chemically induced defence response by 5-HT1 receptor agonists administered into the periaqueductal gray

23 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Differential origin of brainstem serotoninergic projections to the midbrain periaqueductal gray and superior colliculus of the rat.

23 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze.

23 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP)

23 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Behavioural studies on WAY100289, a novel 5-HT3 receptor antagonist, in two animal models of anxiety.

23 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties

23 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

"Paradoxical" effects of morphine on antipredator defense reactions in wild and laboratory rats.

23 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain.

23 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain

23 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex

23 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Comparative effects of chronic 8-OH-DPAT, gepirone and ipsapirone treatment on the sensitivity of somatodendritic 5-HT1A autoreceptors.

23 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Behavioural physiology of serotonergic and steroid-like anxiolytics as antistress drugs

23 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain.

23 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The effect of DAU 6215, a novel 5HT-3 antagonist, in animal models of anxiety.

23 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat.

23 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Evidence that chronic administration of paroxetine or fluoxetine enhances 5-HT2 receptor function in the brain of the guinea pig.

23 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Evidence for opioid and non-opioid forms of stimulation-produced analgesia in the rat.

23 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin 1A receptor agonist.

23 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone

23 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Stimulation of hippocampal 5-HT1A receptors causes amnesia and anxiolytic-like but not antidepressant-like effects in the rat.

23 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis.

23 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam

23 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Physiopharmacological interactions between stress hormones and central serotonergic systems

23 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of chlorisondamine and restraint on cortical [3H]ketanserin binding, 5-HT2A receptor-mediated head shakes, and behaviours in models of anxiety.

23 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Panic and hypertension associated with single dose of buspirone

23 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Evidence for the involvement of 5-HT1A receptors in the anticonflict effect of ipsapirone in rats

23 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Selective neurotoxin lesions of the lateral septum: changes in social and aggressive behaviours.

23 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Double-blind comparison of buspirone and clorazepate in anxious outpatients

23 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.

23 June 2024

55

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM), pentobarbital and methaqualone on punished responding in control and 5,7-dihydroxytryptamine-treated rats

23 June 2024

56

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

23 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Actions of buspirone in a putative model of anxiety in the mouse.

23 June 2024

59

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Exploration of mice in a black and white test box: validation as a model of anxiety.

23 June 2024

60

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse

23 June 2024

61

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The effect of the 5-HT3 receptor antagonist, RS-42358-197, in animal models of anxiety.

23 June 2024

63

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors

23 June 2024

64

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions

23 June 2024

66

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists

23 June 2024

67

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Animal models of anxiety based on classical conditioning: the conditioned emotional response (CER) and the fear-potentiated startle effect

23 June 2024

68

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Excitatory and inhibitory effects of serotonin on sensorimotor reactivity measured with acoustic startle

23 June 2024

69

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone

23 June 2024

71

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

5-HT and mechanisms of defence

23 June 2024

73

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Ascending 5-HT pathways and behavioural habituation.

23 June 2024

75

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Clinical implication of microdialysis findings

23 June 2024

76

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Fluvoxamine treatment for chronic PTSD: a pilot study

23 June 2024

77

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

23 June 2024

79

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Pustative anxiolytics 8-OH-DPAT, buspirone and TVX Q 7821 are agonists at 5-HT1A autoreceptors in the raphé nuclei

23 June 2024

81

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The anti-anxiety and anti-agitation effects of paroxetine in depressed patients

23 June 2024

82

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze

23 June 2024

83

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Serotonergic mechanisms in the behavioral effects of buspirone and gepirone.

23 June 2024

84

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

23 June 2024

85

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Inhibition of Serotonin Synthesis by Para-Chlorophenylalanine in Patients with the Carcinoid Syndrome

23 June 2024

86

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of repeated treatment with 5-HT1A agonists on active avoidance responding in the rat.

23 June 2024

87

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after repeated administration on a conditioned avoidance response (CAR) in the rat

23 June 2024

90

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on locomotor activity and rearing of mice and rats.

23 June 2024

91

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Alteration of 5-HT1A receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography.

23 June 2024

92

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Evidence for the involvement of the 5-HT1A receptor in the anxiolytic action of indorenate and ipsapirone.

23 June 2024

95

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Species differences in the mechanism through which the serotonergic agonists indorenate and ipsapirone produce their anxiolytic action

23 June 2024

96

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Evidence for a postsynaptic action of the serotonergic anxiolytics: ipsapirone, indorenate and buspirone

23 June 2024

97

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Animal models for predicting clinical efficacy of anxiolytic drugs: social behaviour.

23 June 2024

100

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Enhanced anxiolytic effect of zacopride enantiomers in diazepam-withdrawn rats.

23 June 2024

101

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Chemical lesions of both dorsal and median raphe nuclei and changes in social and aggressive behaviour in rats.

23 June 2024

102

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The effects of p-chlorophenylalanine and ethanolamine-O-sulphate in an animal test of anxiety

23 June 2024

103

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat.

23 June 2024

104

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

5,7-Dihydroxytryptamine lesions of dorsal and median raphé nuclei and performance in the social interaction test of anxiety and in a home-cage aggression test

23 June 2024

105

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Depletion in amygdaloid 5-hydroxytryptamine concentration and changes in social and aggressive behaviour

23 June 2024

106

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Anxiety in the rat is associated with decreased release of 5-HT and glycine from the hippocampus.

23 June 2024

107

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The anxiolytic-like effects of 5-hydroxytryptamine3 (5-HT3) receptor antagonists

23 June 2024

108

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors

23 June 2024

109

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. A meta-analysis of eight randomized, controlled studies

23 June 2024

114

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Buspirone increases social investigation in pair-housed male mice; comparison with the effects of chlordiazepoxide

23 June 2024

115

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of acute and subchronic administration of ritanserin on the social behaviour of mice

23 June 2024

116

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Multiple serotonergic influences on startle responding

23 June 2024

121

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Histologic and enzymatic studies of the mesolimbic and mesostriatal serotonergic pathways

23 June 2024

122

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways

23 June 2024

123

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle

23 June 2024

124

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Behavioral studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes

23 June 2024

125

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Anxiolytic profile of GR 38032F in the potentiated startle paradigm

23 June 2024

126

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic

23 June 2024

127

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission.

23 June 2024

128

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The comparative efficacy of buspirone and diazepam in the treatment of anxiety

23 June 2024

129

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Alpha 2-adrenoceptor antagonist activity may account for the effects of buspirone in an anticonflict test in the rat.

23 June 2024

131

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder

23 June 2024

132

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Behavioral inhibition induced by electrical stimulation of the median raphe nucleus of the rat

23 June 2024

134

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effect of metergoline on human anxiety.

23 June 2024

135

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Modulation of the brain aversive system by GABAergic and serotonergic mechanisms.

23 June 2024

136

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Behavioral effects of 5-HT receptor ligands in the aversive brain stimulation, elevated plus-maze and learned helplessness tests.

23 June 2024

137

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Benzodiazepines, putative anxiolytics and animal models of anxiety

23 June 2024

141

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Serenics fluprazine (DU 27716) and eltoprazine (DU 28853) enhance neophobic and emotional behaviour in mice.

23 June 2024

142

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

m-Chlorophenylpiperazine enhances neophobic and anxious behaviour in mice

23 June 2024

143

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Anxiolytic-like effects of a selective 5-HT1A agonist, S20244, and its enantiomers in mice

23 June 2024

144

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effect of chlorimipramine and maprotiline on experimental anxiety in humans.

23 June 2024

145

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Behavioural and biochemical effects following the stimulation of the nucleus Raphis dorsalis in rats

23 June 2024

148

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Pharmacological characterisation of a modified social interaction model of anxiety in the rat.

23 June 2024

149

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

5-HT-the disengaging transmitter?

23 June 2024

152

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

5HT drugs in animal models of anxiety

23 June 2024

153

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs

23 June 2024

154

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors

23 June 2024

155

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of 8-OH-DPAT on ultrasonic vocalization and audiogenic immobility reaction in pre-weanling rats

23 June 2024

156

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The ontogeny of defensive reactions in the rat: Influence of the monoamine transmission systems

23 June 2024

157

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The Anti-Conflict Effect of Drugs Acting On Serotonin System: M Hascoet M Bourin J BradwejnLaboratoire de Pharmacologie, Faculte de Medecine, 44035 Nantes cedex, FRANCE Mc Gill University, Montreal, CANADA

23 June 2024

159

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of ritanserin on aversive classical conditioning in humans.

23 June 2024

160

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists

23 June 2024

161

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection

23 June 2024

162

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Biphasic effect of L-5-HTP in the Vogel conflict model.

23 June 2024

163

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination.

23 June 2024

164

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Partial agonists, full agonists, antagonists: dilemmas of definition

23 June 2024

165

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

5-HT receptors: subtypes and second messengers

23 June 2024

166

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effect of conditioned fear stress on serotonin metabolism in the rat brain

23 June 2024

169

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

23 June 2024

5-HT and anxiety

170

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Structure and function of the brain serotonin system

23 June 2024

171

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Activity of brain serotonergic neurons in the behaving animal

23 June 2024

172

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

5-HT and motor control: a hypothesis

23 June 2024

173

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Opposite control mediated by central 5-HT1A and non-5-HT1A (5-HT1B or 5-HT1C) receptors on periaqueductal gray aversion

23 June 2024

174

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of serotonin receptor antagonists on PAG stimulation induced aversion: different contributions of 5HT1, 5HT2 and 5HT3 receptors

23 June 2024

175

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.

23 June 2024

176

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis

23 June 2024

177

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist

23 June 2024

178

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Stress-induced release of 5-HT in the hippocampus and its dependence on increased tryptophan availability: an in vivo electrochemical study

23 June 2024

179

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Involvement of the dorsal hippocampus in mediation of the antianxiety action of tandospirone, a 5-hydroxytryptamine1A agonistic anxiolytic

23 June 2024

180

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm

23 June 2024

182

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model

23 June 2024

184

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists

23 June 2024

186

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist

23 June 2024

187

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice

23 June 2024

189

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Lack of central 5-hydroxytryptamine influence on the anticonflict activity of diazepam.

23 June 2024

190

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Monoaminergic mechanisms in aversive brain stimulation

23 June 2024

191

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Dorsal raphe nucleus stimulation reduces centrally-elicited fearlike behavior.

23 June 2024

192

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The effect of ipsapirone on behavioural and cardiac responses in the shock-probe/defensive burying test in male rats.

23 June 2024

194

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Intra-hippocampal buspirone in animal models of anxiety.

23 June 2024

195

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

5-Hydroxytryptamine1A receptor agonists in animal models of depression and anxiety

23 June 2024

197

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Ethology and pharmacology of hypothalamic aggression in the rat.

23 June 2024

198

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Modulation of baseline behavior in rats by putative serotonergic agents in three ethoexperimental paradigms

23 June 2024

199

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT

23 June 2024

200

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder

23 June 2024

201

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear.

23 June 2024

202

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations.

23 June 2024

203

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Persistent movement disorders induced by buspirone

23 June 2024

206

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment

23 June 2024

207

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Ethologically-based animal models of anxiety disorders

23 June 2024

209

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Serotonin and psychiatric disorders

23 June 2024

210

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics

23 June 2024

211

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms

23 June 2024

212

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Integrated activity of cardiovascular and pain regulatory systems: role in adaptive behavioural responses

23 June 2024

214

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The periaqueductal gray-rostral medulla connection in the defence reaction: efferent pathways and descending control mechanisms.

23 June 2024

215

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Serotonergic influence from nucleus raphe obscurus on neurones in the periaqueductal grey matter in the rat.

23 June 2024

216

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Influence of the dorsal and median raphe nuclei on neurons in the periaqueductal gray matter: role of 5-hydroxytryptamine.

23 June 2024

217

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The role of the amygdala and dorsal raphe nucleus in mediating the behavioral consequences of inescapable shock.

23 June 2024

219

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands

23 June 2024

221

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Isapirone is a partial agonist at 5-hydroxytryptamine 1A (5-HT1A) receptors in the rat hippocampus: electrophysiological evidence.

23 June 2024

222

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Two tests in rats for antianxiety effect of clinically anxiety attenuating antidepressants.

23 June 2024

223

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of two stressors on behaviour in the elevated X-maze: preliminary investigation of their interaction with 8-OH-DPAT.

23 June 2024

224

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The effects of fenfluramine and fluoxetine on the acquisition of the conditioned avoidance response in rats.

23 June 2024

225

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The DSM-III-R impulse control disorders not elsewhere classified: clinical characteristics and relationship to other psychiatric disorders

23 June 2024

226

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of septal lesions on fear-potentiated startle, and on the anxiolytic effects of buspirone and diazepam.

23 June 2024

228

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Fluvoxamine in the treatment of obsessive compulsive disorder

23 June 2024

232

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effect of lesions of the ascending 5-hydroxytryptaminergic pathways on timing behaviour investigated with an interval bisection task.

23 June 2024

233

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone

23 June 2024

234

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam

23 June 2024

235

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze.

23 June 2024

236

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The future of 5-HT1A receptor agonists. (Aryl-piperazine derivatives)

23 June 2024

238

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effect of the putative 5-HT1A antagonists WAY100135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus

23 June 2024

239

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans

23 June 2024

240

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The role of 5HT1A receptors in the modulation of the acoustic startle reflex in rats

23 June 2024

242

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Sensations Evoked by Stimulation in the Midbrain of Man

23 June 2024

244

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Antagonists at the serotonin-3 receptor can reduce the fear-potentiated startle response in the rat: evidence for different types of anxiolytic activity?

23 June 2024

245

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Review of the side-effect profile of buspirone

23 June 2024

246

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of beta-adrenoceptor ligands in the elevated X-maze 'anxiety' model and antagonism of the 'anxiogenic' response to 8-OH-DPAT.

23 June 2024

248

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

5-HT mediation of the antiaversive effect of isamoltane injected into the dorsal periaqueductal grey

23 June 2024

249

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The pharmacology of human anxiety

23 June 2024

250

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Panic attacks. A neurochemical overview of models and mechanisms

23 June 2024

251

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Involvement of spinal serotonergic pathways in nociception but not in avoidance learning

23 June 2024

252

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety

23 June 2024

253

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Organization of ascending serotonin systems in the adult rat brain. A radioautographic study after intraventricular administration of [3h]5-hydroxytryptamine

23 June 2024

255

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat.

23 June 2024

256

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder

23 June 2024

257

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Fluoxetine and suicidal behaviour. Some clinical and theoretical aspects of a controversy

23 June 2024

260

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Stimulation of postsynaptic 5-HT1A receptors is responsible for the anticonflict effect of ipsapirone in rats.

23 June 2024

261

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effect of diazepam on cortical 5-HT release and behaviour in the guinea-pig on exposure to the elevated plus maze

23 June 2024

264

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

A quantitative interresponse-time analysis of DRL performance differentiates similar effects of the antidepressant desipramine and the novel anxiolytic gepirone

23 June 2024

265

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Comparison of neuroendocrine and behavioral effects of ipsapirone, a 5-HT1A agonist, in three stress paradigms: immobilization, forced swim and conditioned fear

23 June 2024

266

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The effects of p-chlorophenylalanine on experimentally induced conflict in the rat

23 June 2024

267

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone

23 June 2024

269

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Attenuation of defensive analgesia in male mice by 5-HT3 receptor antagonists, ICS 205-930, MDL 72222, MDL 73147EF and MDL 72699

23 June 2024

270

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Role of brain amines in learning associated with "amphetamine-state"

23 June 2024

272

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Equipotentiality of thalamo-amygdala and thalamo-cortico-amygdala circuits in auditory fear conditioning

23 June 2024

273

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Somatosensory and auditory convergence in the lateral nucleus of the amygdala.

23 June 2024

274

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Lesions of the perirhinal cortex but not of the frontal, medial prefrontal, visual, or insular cortex block fear-potentiated startle using a visual conditioned stimulus

23 June 2024

275

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study.

23 June 2024

276

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Rorschach ratings in depressed and suicidal patients with low levels of 5-hydroxyindoleacetic acid in cerebrospinal fluid

23 June 2024

277

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies

23 June 2024

280

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Anti-conflict efficacy of buspirone following acute versus chronic treatment

23 June 2024

281

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Role of the periaqueductal gray substance in the antianxiety action of benzodiazepines

23 June 2024

282

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of dorsal raphe stimulation on escape induced by medial hypothalamic or central gray stimulation.

23 June 2024

283

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat

23 June 2024

284

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Anti-aversive role of serotonin in the dorsal periaqueductal grey matter.

23 June 2024

286

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Stress-induced c-fos expression in the rat brain: activation mechanism of sympathetic pathway.

23 June 2024

288

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis.

23 June 2024

291

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

An important role of the central amygdaloid nucleus and mammillary body in the mediation of conflict behavior in rats

23 June 2024

293

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of benzodiazepine and GABA antagonists on anticonflict effects of antianxiety drugs injected into the rat amygdala in a water-lick suppression test.

23 June 2024

294

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

In vivo measurement of hypothalamic serotonin release by intracerebral microdialysis: significant enhancement by immobilization stress in rats

23 June 2024

295

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Induction of Fos immunoreactivity in the brain by exposure to the elevated plus-maze.

23 June 2024

296

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Serotonergic involvement in conflict behaviour

23 June 2024

298

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The 5,7-DHT-induced anticonflict effect is dependent on intact adrenocortical function

23 June 2024

299

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test

23 June 2024

300

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Intracerebroventricular 5,7-DHT alters the in vitro function of rat cortical GABAA/benzodiazepine chloride ionophore receptor complexes

23 June 2024

301

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Anxiolytic effects of the 5-HT1A receptor agonist ipsapirone in the rat: neurobiological correlates.

23 June 2024

302

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists

23 June 2024

305

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons

23 June 2024

306

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Behavioral effects of selective midbrain raphe lesions in the rat

23 June 2024

307

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety

23 June 2024

308

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of midazolam and 5-HT1A receptor agonists.

23 June 2024

309

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Fenfluramine provocation of anxiety in patients with panic disorder.

23 June 2024

312

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Dopamine and antianxiety activity

23 June 2024

313

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The effects of p-chlorophenylalanine, a serotonin depletor, on avoidance acquisition, pain sensitivity and related behavior in the rat

23 June 2024

314

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Are serotonergic neurons involved in the control of anxiety and in the anxiolytic activity of benzodiazepines?

23 June 2024

315

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The involvement of nigral serotonin innervation in the control of punishment-induced behavioral inhibition in rats.

23 June 2024

316

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Benzodiazepines reduce the tolerance to reward delay in rats

23 June 2024

317

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

A comparison of buspirone and chlordiazepoxide in the shock-probe/burying test for anxiolytics.

23 June 2024

323

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Septal lesions inhibit fear reactions in two animal models of anxiolytic drug action.

23 June 2024

324

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Anxiolytic effects of serotonergic interventions in the shock-probe burying test and the elevated plus-maze test.

23 June 2024

325

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Influence of repeated treatment with buspirone on central 5-hydroxytryptamine and dopamine synthesis

23 June 2024

326

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

A simple and reliable conflict procedure for testing anti-anxiety agents

23 June 2024

328

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Suppression of conditioned avoidance by 8-OH-DPAT in the rat

23 June 2024

329

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Serotonin function in panic disorder: effect of 1-5-hydroxytryptophan in patients and controls.

23 June 2024

330

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Localization of 5-HT1A receptors to astroglial cells in adult rats: implications for neuronal-glial interactions and psychoactive drug mechanism of action.

23 June 2024

331

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effects of serotonergic agents on isolation-induced aggression

23 June 2024

332

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus.

23 June 2024

333

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Cholecystokinin antianalgesia: safety cues abolish morphine analgesia

23 June 2024

334

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtype-selective agonists and antagonists

23 June 2024

335

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Evidence for an involvement of 5-hydroxytryptaminergic neurones in the maintenance of operant behaviour by positive reinforcement

23 June 2024

336

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Does the effect of central 5-hydroxytryptamine depletion on timing depend on motivational change?

23 June 2024

337

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze

23 June 2024

338

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze

23 June 2024

339

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Septal correlates of conditioned inhibition and excitation in rats

23 June 2024

341

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

The role of the lateral septum in anxiolysis.

23 June 2024

342

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Neuroanatomical substrates regulating rat conflict behavior evidenced by brain lesioning.

23 June 2024

343

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Comparison of routes of administration and time course effects of zacopride and buspirone in mice using an automated light/dark test.

23 June 2024

346

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

A fully automated light/dark apparatus useful for comparing anxiolytic agents

23 June 2024

347

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment

23 June 2024

348

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

23 June 2024

349

1 reference

https://api.crossref.org/works/10.1016/0163-7258(95)00004-Z

23 June 2024

Identifiers

1 reference

20 September 2017

1 reference